Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.01
SEM's Cash to Debt is ranked lower than
99% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 0.30 vs. SEM: 0.01 )
Ranked among companies with meaningful Cash to Debt only.
SEM' s 10-Year Cash to Debt Range
Min: 0  Med: 0.01 Max: N/A
Current: 0.01
Equity to Asset 0.19
SEM's Equity to Asset is ranked lower than
82% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. SEM: 0.19 )
Ranked among companies with meaningful Equity to Asset only.
SEM' s 10-Year Equity to Asset Range
Min: -0.09  Med: 0.26 Max: 0.32
Current: 0.19
-0.09
0.32
Interest Coverage 3.33
SEM's Interest Coverage is ranked lower than
69% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 6.81 vs. SEM: 3.33 )
Ranked among companies with meaningful Interest Coverage only.
SEM' s 10-Year Interest Coverage Range
Min: 1.11  Med: 2.03 Max: 3.55
Current: 3.33
1.11
3.55
F-Score: 6
Z-Score: 1.45
M-Score: -2.21
WACC vs ROIC
6.47%
7.31%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 8.97
SEM's Operating margin (%) is ranked higher than
57% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 7.35 vs. SEM: 8.97 )
Ranked among companies with meaningful Operating margin (%) only.
SEM' s 10-Year Operating margin (%) Range
Min: 6.41  Med: 10.01 Max: 13.93
Current: 8.97
6.41
13.93
Net-margin (%) 3.87
SEM's Net-margin (%) is ranked higher than
53% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 3.55 vs. SEM: 3.87 )
Ranked among companies with meaningful Net-margin (%) only.
SEM' s 10-Year Net-margin (%) Range
Min: -1.5  Med: 3.60 Max: 5.12
Current: 3.87
-1.5
5.12
ROE (%) 16.13
SEM's ROE (%) is ranked higher than
73% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 9.02 vs. SEM: 16.13 )
Ranked among companies with meaningful ROE (%) only.
SEM' s 10-Year ROE (%) Range
Min: 10.2  Med: 15.13 Max: 19.74
Current: 16.13
10.2
19.74
ROA (%) 3.88
SEM's ROA (%) is ranked higher than
52% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 3.66 vs. SEM: 3.88 )
Ranked among companies with meaningful ROA (%) only.
SEM' s 10-Year ROA (%) Range
Min: 0.88  Med: 3.93 Max: 5.36
Current: 3.88
0.88
5.36
ROC (Joel Greenblatt) (%) 38.62
SEM's ROC (Joel Greenblatt) (%) is ranked higher than
71% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 16.21 vs. SEM: 38.62 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SEM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 36.58  Med: 45.25 Max: 144.67
Current: 38.62
36.58
144.67
Revenue Growth (3Y)(%) 8.30
SEM's Revenue Growth (3Y)(%) is ranked higher than
53% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. SEM: 8.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SEM' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0  Med: -6.60 Max: 13.1
Current: 8.3
0
13.1
EBITDA Growth (3Y)(%) 5.50
SEM's EBITDA Growth (3Y)(%) is ranked lower than
56% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. SEM: 5.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SEM' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -8.10 Max: 12.8
Current: 5.5
0
12.8
EPS Growth (3Y)(%) 8.10
SEM's EPS Growth (3Y)(%) is ranked lower than
52% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. SEM: 8.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SEM' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: 13.10 Max: 101.4
Current: 8.1
0
101.4
» SEM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

SEM Guru Trades in Q3 2014

Jim Simons 390,300 sh (+265.45%)
Paul Tudor Jones 45,100 sh (+54.88%)
David Dreman 607,425 sh (+1.32%)
Joel Greenblatt 295,804 sh (-5.50%)
Chuck Royce 690,614 sh (-34.73%)
» More
Q4 2014

SEM Guru Trades in Q4 2014

Joel Greenblatt 1,208,598 sh (+308.58%)
David Dreman 649,349 sh (+6.90%)
Jim Simons Sold Out
Chuck Royce 498,114 sh (-27.87%)
Paul Tudor Jones 10,200 sh (-77.38%)
» More
Q1 2015

SEM Guru Trades in Q1 2015

Ken Fisher 2,141,949 sh (New)
Paul Tudor Jones 26,200 sh (+156.86%)
David Dreman 702,539 sh (+8.19%)
Joel Greenblatt Sold Out
Chuck Royce 200,000 sh (-59.85%)
» More
Q2 2015

SEM Guru Trades in Q2 2015

Ken Fisher 3,862,249 sh (+80.31%)
David Dreman 767,655 sh (+9.27%)
Chuck Royce 137,500 sh (-31.25%)
Paul Tudor Jones 16,900 sh (-35.50%)
» More
» Details

Insider Trades

Latest Guru Trades with SEM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 14.00
SEM's P/E(ttm) is ranked higher than
86% of the 148 Companies
in the Global Medical Care industry.

( Industry Median: 27.50 vs. SEM: 14.00 )
Ranked among companies with meaningful P/E(ttm) only.
SEM' s 10-Year P/E(ttm) Range
Min: 7.81  Med: 14.28 Max: 24.61
Current: 14
7.81
24.61
Forward P/E 12.92
SEM's Forward P/E is ranked higher than
78% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 19.23 vs. SEM: 12.92 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 13.50
SEM's PE(NRI) is ranked higher than
89% of the 148 Companies
in the Global Medical Care industry.

( Industry Median: 28.90 vs. SEM: 13.50 )
Ranked among companies with meaningful PE(NRI) only.
SEM' s 10-Year PE(NRI) Range
Min: 7.71  Med: 14.16 Max: 21.47
Current: 13.5
7.71
21.47
P/B 2.12
SEM's P/B is ranked higher than
61% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. SEM: 2.12 )
Ranked among companies with meaningful P/B only.
SEM' s 10-Year P/B Range
Min: 1.09  Med: 1.69 Max: 2.87
Current: 2.12
1.09
2.87
P/S 0.52
SEM's P/S is ranked higher than
82% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. SEM: 0.52 )
Ranked among companies with meaningful P/S only.
SEM' s 10-Year P/S Range
Min: 0.25  Med: 0.47 Max: 0.7
Current: 0.52
0.25
0.7
PFCF 18.30
SEM's PFCF is ranked higher than
61% of the 113 Companies
in the Global Medical Care industry.

( Industry Median: 22.16 vs. SEM: 18.30 )
Ranked among companies with meaningful PFCF only.
SEM' s 10-Year PFCF Range
Min: 4.98  Med: 8.48 Max: 24.48
Current: 18.3
4.98
24.48
POCF 8.17
SEM's POCF is ranked higher than
80% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.76 vs. SEM: 8.17 )
Ranked among companies with meaningful POCF only.
SEM' s 10-Year POCF Range
Min: 3.31  Med: 5.94 Max: 11.06
Current: 8.17
3.31
11.06
EV-to-EBIT 14.03
SEM's EV-to-EBIT is ranked higher than
74% of the 166 Companies
in the Global Medical Care industry.

( Industry Median: 20.01 vs. SEM: 14.03 )
Ranked among companies with meaningful EV-to-EBIT only.
SEM' s 10-Year EV-to-EBIT Range
Min: 7.9  Med: 10.00 Max: 16
Current: 14.03
7.9
16
Shiller P/E 16.35
SEM's Shiller P/E is ranked higher than
83% of the 86 Companies
in the Global Medical Care industry.

( Industry Median: 30.14 vs. SEM: 16.35 )
Ranked among companies with meaningful Shiller P/E only.
SEM' s 10-Year Shiller P/E Range
Min: 11.7  Med: 17.08 Max: 22.14
Current: 16.35
11.7
22.14
Current Ratio 1.54
SEM's Current Ratio is ranked higher than
58% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. SEM: 1.54 )
Ranked among companies with meaningful Current Ratio only.
SEM' s 10-Year Current Ratio Range
Min: 0.86  Med: 1.30 Max: 1.54
Current: 1.54
0.86
1.54
Quick Ratio 1.54
SEM's Quick Ratio is ranked higher than
64% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. SEM: 1.54 )
Ranked among companies with meaningful Quick Ratio only.
SEM' s 10-Year Quick Ratio Range
Min: 0.86  Med: 1.30 Max: 1.54
Current: 1.54
0.86
1.54
Days Sales Outstanding 72.00
SEM's Days Sales Outstanding is ranked lower than
81% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 46.02 vs. SEM: 72.00 )
Ranked among companies with meaningful Days Sales Outstanding only.
SEM' s 10-Year Days Sales Outstanding Range
Min: 39.41  Med: 50.24 Max: 53.97
Current: 72
39.41
53.97

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.31
SEM's Dividend Yield is ranked higher than
68% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.77 vs. SEM: 2.31 )
Ranked among companies with meaningful Dividend Yield only.
SEM' s 10-Year Dividend Yield Range
Min: 1.11  Med: 2.68 Max: 3.48
Current: 2.31
1.11
3.48
Dividend Payout 0.32
SEM's Dividend Payout is ranked higher than
63% of the 134 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. SEM: 0.32 )
Ranked among companies with meaningful Dividend Payout only.
SEM' s 10-Year Dividend Payout Range
Min: 0.37  Med: 0.50 Max: 0.59
Current: 0.32
0.37
0.59
Yield on cost (5-Year) 2.32
SEM's Yield on cost (5-Year) is ranked higher than
56% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 2.12 vs. SEM: 2.32 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
SEM' s 10-Year Yield on cost (5-Year) Range
Min: 1.11  Med: 2.68 Max: 3.48
Current: 2.32
1.11
3.48
Share Buyback Rate 4.90
SEM's Share Buyback Rate is ranked higher than
97% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: -2.30 vs. SEM: 4.90 )
Ranked among companies with meaningful Share Buyback Rate only.
SEM' s 10-Year Share Buyback Rate Range
Min: 0  Med: 4.90 Max: -36.3
Current: 4.9

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.79
SEM's Price/Projected FCF is ranked higher than
88% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.53 vs. SEM: 0.79 )
Ranked among companies with meaningful Price/Projected FCF only.
SEM' s 10-Year Price/Projected FCF Range
Min: 0.63  Med: 0.92 Max: 1.09
Current: 0.79
0.63
1.09
Price/Median PS Value 1.10
SEM's Price/Median PS Value is ranked higher than
54% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 1.12 vs. SEM: 1.10 )
Ranked among companies with meaningful Price/Median PS Value only.
SEM' s 10-Year Price/Median PS Value Range
Min: 0.59  Med: 1.06 Max: 1.48
Current: 1.1
0.59
1.48
Price/Peter Lynch Fair Value 1.72
SEM's Price/Peter Lynch Fair Value is ranked higher than
69% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 2.50 vs. SEM: 1.72 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
SEM' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.48  Med: 2.15 Max: 2.29
Current: 1.72
1.48
2.29
Earnings Yield (Greenblatt) (%) 7.10
SEM's Earnings Yield (Greenblatt) (%) is ranked higher than
79% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. SEM: 7.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SEM' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 6.3  Med: 10.00 Max: 12.7
Current: 7.1
6.3
12.7
Forward Rate of Return (Yacktman) (%) 15.18
SEM's Forward Rate of Return (Yacktman) (%) is ranked higher than
62% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 11.15 vs. SEM: 15.18 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SEM' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -0.2  Med: 10.20 Max: 15.2
Current: 15.18
-0.2
15.2

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 3,525 4,249 4,416
EPS($) 0.95 1.01 1.16
EPS without NRI($) 0.95 1.01 1.16

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Traded in other countries:S24.Germany,
Select Medical Holdings Corp was formed in December 1996. The Company provides long term acute care hospital services and inpatient acute rehabilitative hospital care through its specialty hospital segment and provides physical, occupational and speech rehabilitation services through its outpatient rehabilitation segment. The outpatient rehabilitation reportable segment has two operating segments: outpatient rehabilitation clinics and contract therapy. The Company's specialty hospital segment consists of hospitals designed to serve the needs of long term stay acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care. Patients are admitted to the Company's specialty hospitals from general acute care hospitals. These patients have specialized needs, and serious and often complex medical conditions such as respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes, non-healing wounds, cardiac disorders, renal disorders and cancer. The Company's outpatient rehabilitation segment consists of clinics and contract services that provide physical, occupational and speech rehabilitation services. The Company's outpatient rehabilitation patients are diagnosed with musculoskeletal impairments that restrict their ability to perform normal activities of daily living. As of December 31, 2013, the Company operated 123 specialty hospitals in 28 states, and 1,006 outpatient rehabilitation clinics in 32 states and the District of Columbia. It also provide medical rehabilitation services on a contracted basis to nursing homes, hospitals, assisted living and senior care centers, schools and work sites. The Company competes with Kindred Healthcare Inc., HealthSouth Corporation, Physiotherapy Associates and U.S. Physical Therapy among others. Its healthcare facilities are subject to state and local licensing regulations.
» More Articles for SEM

Headlines

Articles On GuruFocus.com
UnitedHealth Group Reports Strong Second Quarter Earnings Results Jul 21 2015 
Ken Fisher's New Buys in Q1 Apr 30 2015 
Humana And Concentra To Part Ways Mar 27 2015 
Weekly Highlight of CEO Sells Oct 13 2014 
Invesco’s Wilbur Ross, Real-Time and Review Nov 14 2013 
Distressed Investor Wilbur Ross Buys 2 Stocks May 16 2013 
My 4 High Dividend-Paying Favorites from the Share Buyback Achievers Index May 13 2013 
physical therepy Jan 09 2013 
Select Medical Corp. Reports Operating Results (10-Q) Nov 12 2010 
Select Medical Corp. Reports Operating Results (10-Q) Aug 12 2010 

More From Other Websites
SELECT MEDICAL HOLDINGS CORP Financials Aug 18 2015
SELECT MEDICAL HOLDINGS CORP Files SEC form 8-K/A, Completion of Acquisition or Disposition of... Aug 14 2015
10-Q for Select Medical Holdings Corp. Aug 08 2015
SELECT MEDICAL HOLDINGS CORP Files SEC form 8-K, Change in Directors or Principal Officers Aug 07 2015
Edited Transcript of SEM earnings conference call or presentation 7-Aug-15 1:00pm GMT Aug 07 2015
SELECT MEDICAL HOLDINGS CORP Files SEC form 10-Q, Quarterly Report Aug 06 2015
Select Medical Holdings Corporation Announces Results for Second Quarter Ended June 30, 2015 Aug 06 2015
Q2 2015 Select Medical Holdings Corp Earnings Release - After Market Close Aug 06 2015
SELECT MEDICAL HOLDINGS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jul 24 2015
Transitional Care Unit at Penn State Hershey Rehabilitation Hospital Earns Coveted Five-Star Rating... Jul 15 2015
Select Medical downgraded by UBS Jul 13 2015
Is Select Medical Holdings an Incredible Value Stock? 3 Reasons Why SEM Will Be Tough to Beat - Tale... Jul 06 2015
Select Medical Holdings Corporation to Announce Second Quarter 2015 Results on Thursday, August 6 Jul 01 2015
Ochsner Health System And Select Medical Form Strategic Partnership And Announce New 60-Bed Hospital Jun 29 2015
Why You Shouldn't Bet Against Select Medical Holding (SEM) Stock - Tale of the Tape Jun 26 2015
SELECT MEDICAL HOLDINGS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 22 2015
Government Declines to Intervene in Action against Select Medical Corporation Jun 19 2015
SELECT MEDICAL HOLDINGS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jun 05 2015
Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through... Jun 01 2015
Select Medical Hits 52-Week High on Strong Q1 Performance - Analyst Blog May 26 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK